Gastrointestinal complications in pediatric lung transplant recipients : Incidence, risk factors, and effects on patient outcomes
Abstract Background Gastrointestinal (GI) complications in lung transplant recipients can occur any time during the post‐operative period, leading to prolonged morbidity and mortality. Despite the negative association between GI complications and patient outcomes, little is known about their incidence and risk factors for their development in pediatric lung transplant recipients. Methods We performed a retrospective chart review at one pediatric tertiary center to describe the frequency of GI complications in lung transplant recipients. We identified potential risk factors for the diagnosis of gastroparesis, gastroesophageal reflux disease (GERD) and aspiration in the post‐transplant period. Lastly, we investigated the association of these complications with mortality and graft survival. Results84.3% of lung transplant recipients experienced at least one GI complication in the post‐transplant period. Gastroparesis (52.9%), GERD (41.2%), and oropharyngeal dysphagia/laryngeal penetration (33.3%) were the most common complications diagnosed. Post‐operative opioid exposure was a risk factor for gastroparesis, with the odds increasing 3.0% each day a patient was prescribed opioids ( p = .021). The risk of death or retransplant in individuals who experienced gastroparesis was 2.7 times higher than those not diagnosed with gastroparesis ( p = .027). Conclusion Exposure to opioids in the post‐operative period is a risk factor for gastroparesis and a prolonged hospitalization placed patients at risk for aspiration. Gastroparesis was associated with increased patient mortality and graft failure, while aspiration and GERD had no effect on long term outcomes. Future prospective studies investigating the relationship between opioid use and the development of a gastroparesis are necessary to improve patient outcomes..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Pediatric Transplantation - 28(2024), 1 |
| Beteiligte Personen: |
Klouda, Timothy [VerfasserIn] |
|---|
| Anmerkungen: |
© 2024 Wiley Periodicals, LLC. |
|---|
| Umfang: |
9 |
|---|
| doi: |
10.1111/petr.14665 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY018125093 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY018125093 | ||
| 003 | DE-627 | ||
| 005 | 20240422233047.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240422s2024 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/petr.14665 |2 doi | |
| 028 | 5 | 2 | |a 2024-04-22_PETR_2024_28_1.zip.xml |
| 035 | |a (DE-627)WLY018125093 | ||
| 035 | |a (WILEY)PETR14665 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Klouda, Timothy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Gastrointestinal complications in pediatric lung transplant recipients |b Incidence, risk factors, and effects on patient outcomes |
| 264 | 1 | |c 2024 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2024 Wiley Periodicals, LLC. | ||
| 520 | |a Abstract Background Gastrointestinal (GI) complications in lung transplant recipients can occur any time during the post‐operative period, leading to prolonged morbidity and mortality. Despite the negative association between GI complications and patient outcomes, little is known about their incidence and risk factors for their development in pediatric lung transplant recipients. Methods We performed a retrospective chart review at one pediatric tertiary center to describe the frequency of GI complications in lung transplant recipients. We identified potential risk factors for the diagnosis of gastroparesis, gastroesophageal reflux disease (GERD) and aspiration in the post‐transplant period. Lastly, we investigated the association of these complications with mortality and graft survival. Results84.3% of lung transplant recipients experienced at least one GI complication in the post‐transplant period. Gastroparesis (52.9%), GERD (41.2%), and oropharyngeal dysphagia/laryngeal penetration (33.3%) were the most common complications diagnosed. Post‐operative opioid exposure was a risk factor for gastroparesis, with the odds increasing 3.0% each day a patient was prescribed opioids ( p = .021). The risk of death or retransplant in individuals who experienced gastroparesis was 2.7 times higher than those not diagnosed with gastroparesis ( p = .027). Conclusion Exposure to opioids in the post‐operative period is a risk factor for gastroparesis and a prolonged hospitalization placed patients at risk for aspiration. Gastroparesis was associated with increased patient mortality and graft failure, while aspiration and GERD had no effect on long term outcomes. Future prospective studies investigating the relationship between opioid use and the development of a gastroparesis are necessary to improve patient outcomes. | ||
| 700 | 1 | |a Ryan E, Morgan |4 aut | |
| 700 | 1 | |a Leonard, Jessica Brie |4 aut | |
| 700 | 1 | |a Freiberger, Dawn |4 aut | |
| 700 | 1 | |a Midyat, Levent |4 aut | |
| 700 | 1 | |a Dahlberg, Suzanne |4 aut | |
| 700 | 1 | |a Rosen, Rachel |4 aut | |
| 700 | 1 | |a Visner, Gary |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric Transplantation |g 28(2024), 1 |w (DE-627)WLY012262315 |x 13993046 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:1 |g extent:9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2024 |e 1 |g 9 | ||